文献速递甲状腺疾病

家族性非髓样甲状腺癌的筛查结果

Results of Screening in Familial Non-Medullary Thyroid Cancer.
PubMed 文献 · Thyroid · 2017-07-19

这项前瞻性队列研究对家族性非髓样甲状腺癌(FNMTC)高危亲属每年进行颈部超声及>0.5 cm结节细针穿刺筛查。两个成员受累家族的高危个体检出甲状腺癌4.6%(2/43),三个及以上成员受累家族为22.7%(15/66)(p=0.01)。筛查检出者肿瘤更小、中央区淋巴结转移更少、手术范围更小、放射性碘治疗更少。

要点

  • 三个及以上成员受累的FNMTC家族高危成员筛查检出甲状腺癌22.7%(15/66)。
  • 筛查检出者较入组时已患病者肿瘤更小、中央区淋巴结转移更少。
  • 作者建议三个及以上成员受累的FNMTC家族考虑甲状腺超声筛查,但需谨慎。

核心结论

  • 对高危家族成员筛查可实现低危FNMTC的早期检出,并与初始治疗强度较低相关。

研究设计与样本

  • 前瞻性队列研究,对高危个体每年筛查,采用颈部超声及对>0.5 cm甲状腺结节行细针穿刺活检。
  • 入组标准为两个及以上一级亲属患甲状腺癌且年龄大于7岁,共纳入25个家族(12个家族2名成员受累,13个家族3名及以上成员受累)。

主要发现

  • 筛查检出甲状腺癌比例:两个成员受累家族为4.6%(2/43),三个及以上成员受累家族为22.7%(15/66)(p=0.01)。
  • 筛查检出者肿瘤大小0.7 ± 0.5 cm vs 入组时已患病者1.5 ± 1.1 cm(p=0.006)。
  • 筛查检出者中央区颈部淋巴结转移率17.6% vs 入组时已患病者51.1%(p=0.02)。
  • 筛查检出者行甲状腺半切除术比例23.5% vs 入组时已患病者0%(p=0.002)。
  • 筛查检出者接受放射性碘治疗比例23.5% vs 入组时已患病者79%(p<0.001)。

临床怎么用

  • 作者认为,三个及以上家族成员受累的FNMTC家族应考虑甲状腺超声筛查。
  • 作者指出,积极筛查可能与过度治疗风险相关,应谨慎实施,尤其是老年个体。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Although a family history of thyroid cancer is one of the main risk factors for thyroid cancer, the benefit of screening individuals with a family history of thyroid cancer is not known. METHODS: A prospective cohort study was performed with yearly screening using neck ultrasound and fine-needle aspiration biopsy of thyroid nodule(s) >0.5 cm in at-risk individuals whose relatives were diagnosed with familial non-medullary thyroid cancer (FNMTC). The eligibility criteria were the presence of thyroid cancer in two or more first-degree relatives and being older than seven years of age. Twenty-five kindred were enrolled in the study (12 families with two members affected, and 13 with three or more members affected at enrollment). RESULTS: Thyroid cancer was detected by screening in 4.6% (2/43) of at-risk individuals from families with two members affected, and in 22.7% (15/66) of at-risk members from families with three or more patients affected (p = 0.01). FNMTC detected by screening was characterized by a smaller tumor size (0.7 ± 0.5 cm vs. 1.5 ± 1.1 cm; p = 0.006), a lower rate of central neck lymph node metastases (17.6% vs. 51.1%; p = 0.02), less extensive surgery (hemithyroidectomy 23.5% vs. 0%; p = 0.002), and a lower rate of radioactive iodine therapy (23.5% vs. 79%; p < 0.001) compared to those affected at enrollment. CONCLUSIONS: Screening of at-risk family members resulted in earlier detection of low-risk FNMTC and was associated with a less aggressive initial treatment. Screening with thyroid ultrasound should be considered in kindred with three or more family members affected by FNMTC. Since active screening might be associated with the risk of overtreatment, it should be implemented with caution, specifically in elderly individuals.

来源:Thyroid,查看原文。版权归原作者所有。

引用

  1. Klubo-Gwiezdzinska J, Yang L, Merkel R, et al. Results of Screening in Familial Non-Medullary Thyroid Cancer. Thyroid. 2017. PMID: 28657510. doi:10.1089/thy.2016.0668

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。